Cameron Kevin J 4
4 · Ionetix Corp / DE / · Filed May 13, 2026
Research Summary
AI-generated summary of this filing
Ionetix CEO Kevin J. Cameron Receives Award (Merger)
What Happened
Kevin J. Cameron, President and CEO of Ionetix Corp., was granted and received a total of approximately 7,206,409 shares and derivative awards on April 9, 2026. The largest single item reported was 5,306,782 shares received in connection with the issuer's merger with Legacy Ionetix; the remainder are additional share awards and several derivative awards (options) adjusted or issued under the merger. No cash price per share is reported (N/A), so the filing does not state a dollar value for these awards.
Key Details
- Transaction date: April 9, 2026 (reported on Form 4 filed May 13, 2026). Filing appears late — Form 4s are normally due within two business days of the transaction.
- Reported items (aggregate): ~7,206,409 shares/awards acquired (individual line items include 5,306,782; 205,932; 206,209; 501,400; 334,266; and four grants of 162,955).
- Consideration / price: N/A (awards/merger consideration; no cash price reported).
- Conversion ratio: Under the Merger Agreement, each Legacy Ionetix share converted into 0.5014 shares of the issuer.
- Derivatives / options: Several entries are derivative awards (options). Footnotes indicate some options were fully vested and exercisable, others vest monthly over 48 months beginning on various start dates (Jan 15, 2025; Mar 17, 2026; Mar 27, 2026). Options were adjusted in connection with the merger.
- Beneficial ownership: The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest (footnote).
- Shares owned after transaction: Not specified in this filing.
Context
These transactions are largely non‑cash awards resulting from the April 9, 2026 merger (and conversion/adjustment of pre‑existing options). Derivative entries reflect options or option-like awards that vest over time or are already exercisable — they do not necessarily represent immediately tradable common shares until exercised or vested. Because no per‑share price or dollar amounts are reported here, investors should refer to company disclosures or market prices to estimate the economic value. The Form 4 was filed about a month after the transaction date, which is later than the usual two‑business‑day reporting window for insider trades.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-09+5,306,782→ 5,306,782 total - Award
Common Stock
[F1][F2]2026-04-09+205,932→ 205,932 total(indirect: By daughter) - Award
Common Stock
[F1][F2]2026-04-09+206,209→ 206,209 total(indirect: By son) - Award
Stock Option (Right to Buy)
[F4][F3]2026-04-09+501,400→ 501,400 totalExercise: $0.32Exp: 2028-08-09→ Common Stock (501,400 underlying) - Award
Stock Option (Right to Buy)
[F4][F3]2026-04-09+334,266→ 334,266 totalExercise: $0.38Exp: 2030-06-08→ Common Stock (334,266 underlying) - Award
Stock Option (Right to Buy)
[F4][F3]2026-04-09+162,955→ 162,955 totalExercise: $0.62Exp: 2034-01-14→ Common Stock (162,955 underlying) - Award
Stock Option (Right to Buy)
[F4][F5]2026-04-09+162,955→ 162,955 totalExercise: $0.62Exp: 2034-01-14→ Common Stock (162,955 underlying) - Award
Stock Option (Right to Buy)
[F4][F6]2026-04-09+162,955→ 162,955 totalExercise: $0.98Exp: 2035-03-26→ Common Stock (162,955 underlying) - Award
Stock Option (Right to Buy)
[F4][F7]2026-04-09+162,955→ 162,955 totalExercise: $0.98Exp: 2035-03-16→ Common Stock (162,955 underlying)
Footnotes (7)
- [F1]Received in connection with the Issuer's merger (the "Merger") with Ionetix Corporation ("Legacy Ionetix") in accordance with the terms of the Agreement and Plan of Merger and Reorganization dated as of April 9, 2026 (the "Merger Agreement"), by and among the Issuer (f/k/a JDEV Acquisition Corp.), JDEV Merger Subsidiary and Legacy Ionetix. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Ionetix common stock was entitled to receive 0.5014 (the "Conversion Ratio") shares of the Issuer's Common Stock. The Merger closed on April 9, 2026.
- [F2]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F3]The stock option is fully vested and exercisable.
- [F4]Received in connection with the Merger in exchange for options to acquire shares of Legacy Ionetix common stock adjusted by the Conversion Ratio.
- [F5]The stock option vests in 48 monthly installments beginning on January 15, 2025.
- [F6]The stock option vests in 48 monthly installments beginning on March 27, 2026.
- [F7]The stock option vests in 48 monthly installments beginning on March 17, 2026.